#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14538	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2046	707.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1705	1705	T	846	T	753	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14538	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2046	707.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1439	1439	C	925	C	845	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26248	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3567	733.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1666	1666	A	852	A	770	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26248	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3567	733.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	876	C	792	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26248	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3567	733.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	877	A	805	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26248	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3567	733.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	824	C	764	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26248	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3567	733.6	0	HET	.	.	.	C1287T,A	.	1287	1287	C	1616	1616	C	822	C,T,A	517,208,1	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2132	folP	855	855	99.88	folP.l15.c4.ctg.1	1433	147.5	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	968	970	AGC	199;199;201	A;G;C	184;181;182	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5612	gyrA	2751	2751	99.96	gyrA.l15.c17.ctg.1	3399	164.6	0	.	p	.	0	G95A	NONSYN	283	285	GGC	643	645	GCC	182;185;184	G;C;C	163;167;166	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5612	gyrA	2751	2751	99.96	gyrA.l15.c17.ctg.1	3399	164.6	1	SNP	p	S91F	1	.	.	271	273	TTC	631	633	TTC	197;192;192	T;T;C	180;177;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1670	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1263	131.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	388	390	ACC	223;223;224	A;C;C	197;202;203	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1670	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1263	131.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	586	588	CAC	204;207;208	C;A;C	188;188;190	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1670	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1263	131.8	0	.	p	.	0	A127fs	FSHIFT	379	379	G	652	652	G	229	G,A	209,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1670	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1263	131.8	1	SNP	p	G45D	0	.	.	133	135	GGC	406	408	GGC	225;224;227	G;G;C	201;200;202	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	866	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	996	86.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1427	1429	GTC	207;208;206	G;T;C	189;191;186	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	1	SNP	p	D86N	0	.	.	256	258	GAC	533	535	GAC	217;216;216	G;A;C	197;194;197	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	1	SNP	p	S87R	1	.	.	259	261	CGT	536	538	CGT	215;215;218	C,A;G;T	196,1;195;198	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	1	SNP	p	R87I	0	.	.	259	261	CGT	536	538	CGT	215;215;218	C,A;G;T	196,1;195;198	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	1	SNP	p	R87W	0	.	.	259	261	CGT	536	538	CGT	215;215;218	C,A;G;T	196,1;195;198	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5098	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2999	169.4	1	SNP	p	S88P	0	.	.	262	264	TCC	539	541	TCC	219;221;226	T;C;C	201;201;208	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4480	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2618	170.2	0	.	p	.	0	T169I	NONSYN	505	507	ACC	781	783	ATC	184;184;184	A;T,C;C	167;167,1;170	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4480	parE	1986	1986	99.9	parE.l15.c17.ctg.1	2618	170.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	232;233;231	G;G;C	213;211;206	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1303	1305	GCA	207;209;210	G;C;A	190;192;193	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1306	1308	ATC	209;209;208	A;T;C	192;188;189	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1318	1320	GTG	209;207;209	G;T;G	191;189;191	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1318	1320	GTG	209;207;209	G;T;G	191;189;191	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1822	1824	ACC	211;212;215	A;C;C	197;198;202	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1876	1878	GCG	229;225;224	G,T;C;G	198,1;182;190	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1876	1878	GCG	229;225;224	G,T;C;G	198,1;182;190	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1999	2001	GGT	175;176;173	G;G;T	162;164;159	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2008	2010	GGC	163;163;165	G;G;C	152;150;152	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4070	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2439	166.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2026	2028	CCG	151;152;147	C,G;C;G	109,5;110;109	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6012	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3105	193.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1730	1732	CCG	234;236;233	C;C;G	207;215;209	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2216	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1737	126.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	161	C	146	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	0	.	p	.	0	R143G	NONSYN	427	429	AGA	608	610	GGA	257;258;260	G,C;G,A;A,C	232,1;229,1;230,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	0	.	p	.	0	.	INDELS	629	630	AA	811	813	TAG	229;230;231	T;A;G	208;205;208	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	0	.	p	.	0	.	MULTIPLE	631	633	TAC	815	818	CAAT	232;232;229;230	C;A;A;T	213;212;210;212	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	0	.	p	.	0	N212fs	FSHIFT	634	634	A	820	820	T	230	T	216	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	1	SNP	p	G120K	0	.	.	358	360	GGT	539	541	GGT	264;262;266	G;G;T,C	241;238;241,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	1	SNP	p	A121N	0	.	.	361	363	GCC	542	544	GCC	266;262;261	G;C;C	244;241;239	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2836	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1367	204.5	1	SNP	p	A121D	0	.	.	361	363	GCC	542	544	GCC	266;262;261	G;C;C	244;241;239	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10616	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4924	215.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2066	2068	AAT	228;229;232	A;A;T	215;217;219	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1186	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	991	118.8	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	251;251;250	A;T;G	239;239;238	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	844	846	ACG	424;410;410	A;C;G,A	403;393;391,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	865	867	GAC	352;353;348	G;A;C	348;347;346	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	883	885	ATG	319;315;318	A;T;G	319;314;317	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	895	897	TCA	313;310;311	T;C;A	312;310;311	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	940	942	CAG	299;299;301	C;A;G	290;289;291	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	961	963	CTT	289;289;289	C;T;T	281;282;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	982	984	AGT	313;318;324	A;G;T	296;299;298	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1051	1053	CCG	474;473;484	C;C;G	433;435;444	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1153	1155	TCG	579;571;571	T;C;G,A	512;505;505,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1324	1326	AAA	284;279;273	A;A;A	269;265;260	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1327	1329	AAG	271;273;271	A;A;G	258;258;257	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1342	1344	CAC	220;217;215	C;A;C	219;204;213	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1381	1383	GAA	195;193;192	G,A;A;A	193,1;192;189	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1459	1461	ACG	155;155;154	A;C;G	153;152;153	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1510	1512	ATT	230;228;229	A;T;T	207;204;206	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1513	1515	AGT	227;226;225	A;G;T	205;204;202	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1552	1554	CTA	233;235;240	C;T;A	215;215;219	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1594	1596	AAT	147;148;151	A;A;T	146;147;148	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1663	1665	TCA	257;255;254	T;C;A	239;234;234	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1687	1689	ATG	274;273;275	A;T;G	255;255;255	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	1981	1983	ACC	671;669;666	A;C;C,T	608;615;613,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10620	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	2534	417.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2077	2079	GAA	587;589;590	G;A;A	539;545;544	.	Tetracycline resistance
